Resolution of warts during interleukin-2 immunotherapy.
Ades
E W
EW
Biological Products Branch, Centers for Disease Control, U.S. Department of Health and Human Services, Atlanta, Ga.
Gillespie
T
T
D002292:Carcinoma, Renal Cell / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D014860:Warts / Q000628:therapy*
D007376:Interleukin-2